Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPEFree Report) in a research report report published on Thursday morning. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of NYSE:AMPE opened at $0.00 on Thursday. Ampio Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $7.47. The firm has a market capitalization of $2,497.00, a PE ratio of 0.00 and a beta of 3.67. The business’s 50 day moving average price is $0.03 and its 200-day moving average price is $0.43.

Ampio Pharmaceuticals Company Profile

(Get Free Report)

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

See Also

Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.